Summary
The effects of 4-aminopyridine (4-AP) on the turnovers of 5-hydroxytryptamine, dopamine and noradrenaline in the central nervous system of rats were studied by means of amine disappearance following inhibition of tryptophan or tyrosine hydroxylase. 4-AP (3 mg/kg i.p.) did not change the utilizations of 5-hydroxytryptamine or dopamine but it markedly accelerated that of noradrenaline in the brain and in the spinal cord. This stimulatory effect of 4-AP was completely dependent on nerve impulses since no effect was observed following an acute section of the noradrenaline nerves to the spinal cord. The effect of 4-AP was blocked by theα-adrenoreceptor stimulating agent clonidine. Pentylenetetrazole, at a dose producing similar behavioural changes as 4-AP, caused only a slight stimulation of the noradrenaline turnover. 4-AP might enhance the flux of calcium ions into nerve terminals during depolarization, and thus increase the release of noradrenaline, whereas this process might be of less importance in the dopamine and the 5-hydroxytryptamine nerves.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén, N.-E., Corrodi, H., Dahiström, A., Fuxe, K., Hökfelt, T. Effects of tyrosine hydroxylase inhibition on the amine levels of central monoamine neurons. Life Sci.5, 561–568 (1966 a).
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, T. Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci.9 (I), 513–523 (1970).
Andén, N.-E., Corrodi, H., Fuxe, K., Ungerstedt, U. Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. Eur. J. Pharmacol.15, 193–199 (1971).
Andén, N.-E., Fuxe, K., Hökfelt, T. The importance of the nervous impulse flow for the depletion of the monoamines from central neurones by some drugs. J. Pharm. Pharmacol.18, 630–632 (1966 b).
Andén, N.-E., Grabowska, M., Strömbom, U. Different alpha-adreno-receptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol.292, 43–52 (1976).
Andén, N.-E., Häggendal, J., Magnusson, T., Rosengren, E. The time course of the disappearance of noradrenaline and 5-hydroxytryptamine in the spinal cord after transection. Acta physiol. scand.62, 115–118 (1964).
Arbilla, S., Langer, S. Z. Morphine andβ-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum. Nature271, 559–561 (1978).
Atack, C. V. The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay. Br. J. Pharmacol.48, 699–714 (1973).
Atack, C. V., Lindqvist, M. Conjoint native and orthophthaldialdehyde-condensate assays for the fluorimetric determination of 5-hydroxyindoles in brain. Naunyn-Schmiedeberg's Arch. Pharmacol.279, 267–284 (1973).
Atack, C. V., Magnusson, T. Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures. J. Pharm. Pharmacol.22, 625–627 (1970).
Baldessarini, R. J., Kopin, I. J. The effect of drugs on the release of norepinephrine-3H from central nervous system tissues by electrical stimulation in vitro. J. Pharmacol. exp. Ther.156, 31–38 (1967).
Bertler, Å., Carlsson, A., Rosengren, E. A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta physiol. scand.44, 273–292 (1958).
Carlsson, A., Corrodi, H., Waldeck, B. α-Substituierte Dopacetamide als Hemmer der Catechol-O-Methyl-Transferase und der enzymatischen Hydroxilierung aromatischer Aminosäuren. In den Catecholamin-Metabolismus eingreifende Substanzen 2. Mitteilung. Helv. chim. Acta46, 2271–2285 (1963).
Carlsson, A., Falck, B., Fuxe, K., Hillarp, N.-Å. Cellular localization of monoamines in the spinal cord. Acta physiol. scand.60, 112–119 (1964).
Chase, T. N., Katz, R. I., Kopin, I. J. Release of [3H]serotonin from brain slices. J. Neurochem.16, 607–615 (1969).
Corrodi, H., Fuxe, K., Lidbrink, P., Olson, L. Minor tranquillizers, stress and central catecholamine neurons. Brain Res.29, 1–16 (1971).
Corrodi, H., Hanson, L. C. F. Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia10, 116–125 (1966).
Farnebo, L.-O. Release of monoamines evoked by field stimulation-studies on some ionic and metabolic requirements. Acta physiol. scand., Suppl.371, 19–27 (1971).
Häggendal, J. An improved method for fluorimetric determination of small amounts of adrenaline and noradrenaline in plasma and tissues. Acta physiol. scand.59, 242–254 (1963).
Jankowska, E., Lundberg, A., Rudomin, P., Sykova, E. Effects of 4-aminopyridine on transmission in excitatory and inhibitory synapses in the spinal cord. Brain Res.136, 387–392 (1977).
Johns, A., Golko, D. S., Lauzon, P. A., Paton, D. M. The potentiating effects of 4-aminopyridine on adrenergic transmission in the rabbit vas deferens. Eur. J. Pharmacol.38, 71–78 (1976).
Katz, B. The release of neural transmitter substances. The Sherrington Lectures10, pp. 1–55. Liverpool: Liverpool University Press. 1969.
Leander, S., Arner, A., Johansson, B. Effects of 4-aminopyridine on mechanical activity and noradrenaline release in the rat portal vein in vitro. Eur. J. Pharmacol.46, 351–361 (1977).
Lemeignan, M. Abord pharmacologique de l'étude du mécanisme de l'action convulsivante de Pamino-4-pyridine. Thérapie26, 927–940 (1971).
Lundh, H., Leander, S., Thesleff, S. Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine. J. neurol. Sci.32, 29–43 (1977).
Lundh, H., Thesleff, S. The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals. Eur. J. Pharmacol.42, 411–412 (1977).
Magnusson, T., Rosengren, E. Catecholamines of the spinal cord normally and after transection. Experientia19, 229 (1963).
Molgo, J., Lemeignan, M., Lechat, P. Effects of 4-aminopyridine at the frog neuromuscular junction. J. Pharmacol. exp. Ther.203, 653–663 (1977).
Pelhate, H., Pichon, Y. Selective inhibition of potassium current in the giant axon of the cockroach. J. Physiol. (Lond.)242, 90P-91P (1974).
Starke, K., Mantel, H. Involvement ofα-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology12, 1073–1080 (1973).
Svensson, T. H., Bunney, B. S., Aghajanian, G. K. Inhibition of both nor-adrenergic and serotonergic neurons in brain by theα-adrenergic agonist clonidine. Brain Res.92, 291–306 (1975).
Vizi, E. S., Dijk, J. van, Foldes, F. F. The effect of 4-aminopyridine on acetylcholine release. J. Neural Transm.41, 265–274 (1977).
Yeh, J. Z., Oxford, G. S., Wu, C. H., Narahashi, T. Interactions of aminopyridines with potassium channels of squid axon membranes. Biophys. J.16, 77–87 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andén, N.E., Leander, S. Effects of 4-aminopyridine on the turnover of monoamines in the central nervous system of the rat. J. Neural Transmission 44, 1–12 (1979). https://doi.org/10.1007/BF01252697
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01252697